Our industry has a 200% drug supply overage problem in clinical trials. Study organizers often supply individually per study, some of which are complex or multi-phase studies. Many study sponsors tend to package “too much” or “too early,” to be…
Clinerion and S4 Research Partner to Accelerate the Introduction of Innovative Medical Treatments to India
Clinerion and S4 Research announce a partnership to expand the global network of hospitals on the Clinerion’s Patient Network Explorer platform into India. International pharmaceutical companies will be able to match their leading-edge clinical trials to patients in India. …
Novotech and CNS Deal Expands CRO Services for Biopharma Clients Across Asia-Pacific
Novotech the largest Asia-Pacific-based CRO has acquired Australasian specialist CRO Clinical Network Services (CNS) as part of a mutual mission to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials.…
Number of UK clinical trials in decline since Brexit vote
Ongoing uncertainty and concern about Brexit has already cut the number of clinical trials carried out in the UK. The number of drug trials started in Britain in 2017 was a staggering 25% lower than the average for 2009-2016. A…
Drug firms retaining old brand names for new medicines
Pharma firms prefer to go with the existing brand names for new fixed dose combinations (FDCs) as it is easier to market them What’s in a name? A lot, according to pharmaceutical companies, many of whom have already launched or…
